Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update

  title={Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update},
  author={Paul Hewitson and Paul P. Glasziou and Eila K Watson and Bernie Towler and Les M. Irwig},
  journal={The American Journal of Gastroenterology},
BACKGROUND AND AIMS:Reducing mortality from colorectal cancer (CRC) may be achieved by the introduction of population-based screening programs. The aim of the systematic review was to update previous research to determine whether screening for CRC using the fecal occult blood test (FOBT) reduces CRC mortality and to consider the benefits, harms, and potential consequences of screening.METHODS:We searched eight electronic databases (Cochrane Library, MEDLINE, EMBASE, CINAHL, PsychINFO, AMED… 

Figures and Tables from this paper

Potential biases in colorectal cancer screening using faecal occult blood test.

The 16% RRR in CRC mortality found in the updated Cochrane review's meta-analysis is overestimated and the biases identified were specific to CRC screening: type of diagnostic method, place of surgery and diagnostic delay.

Comparison of Uptake of Colorectal Cancer Screening Based on Fecal Immunochemical Testing (FIT) in Males and Females: A Systematic Review and Meta-analysis

Meta analysis of FIT screening studies indicates significantly lower uptake among men, and further investigation is required into factors influencing acceptability and participation of F IT screening in both sexes.

Dietary interventions for fecal occult blood test screening: systematic review of the literature.

  • G. Konrad
  • Medicine
    Canadian family physician Medecin de famille canadien
  • 2010
Most of the evidence evaluating the effect of dietary restrictions on FOBT results is dated and of suboptimal quality, however, 4 RCTs and a meta-analysis of these data do not support dietary restrictions when screening for colorectal cancer.

Colorectal Cancer Screening: Have We Addressed Concerns and Needs of the Target Population?

The general population preferred either colonoscopy as the most accurate test, or fecal occult blood test (FOBT) as the least invasive for CRC screening, suggesting test alternatives and tailoring the content and delivery of screening information to the public’s preferences are needed.

Fecal Occult Blood Test and Colorectal Cancer: Validation Study with Special Reference to False-Negative Patients

  • T. Kawada
  • Medicine
    Digestive Diseases and Sciences
  • 2013
A FN result of FOBT is associated with increased mortality from CRC, and Cox regression analysis of survival after adjustment for gender, age, medication history, and comorbidities showed a threefold higher mortality in the FN group as compared with that in the PC group.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

This evidence review examined the effectiveness and cost-effectiveness of fecal occult blood testing (FOBT) and immunochemical FOBT (iFOBT), for use in colorectal cancer screening in asymptomatic, average-risk adults.

A Global Evaluation of the Performance Indicators of Colorectal Cancer Screening with Fecal Immunochemical Tests and Colonoscopy: A Systematic Review and Meta-Analysis

A systematic review and meta-analysis of international literature on the achievements of various performance indicators for colorectal cancer screening programs that used the fecal immunochemical test (FIT) as a primary screening modality and colonoscopy as a subsequent confirmatory test to identify the areas that could be improved and finally optimize the CRC screening programs.

Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.

To compare the diagnostic test accuracy of gFOBT and FIT screening for detecting advanced colorectal neoplasia in average-risk individuals, the Rutter and Gatsonis hierarchical summary receiver operating characteristic model was used, and the bivariate hierarchical model to estimate sensitivity and specificity at common thresholds.

Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis.

This meta-analysis suggests that screening FS can reduce the incidence of proximal anddistal CRC and mortality from distal CRC along with reduction in diagnosis of advanced CRC.

Incomplete diagnostic follow-up after a positive colorectal cancer screening test: a systematic review

  • A. Dalton
  • Medicine
    Journal of public health
  • 2018
Although rates of non-attendance in those eligible are low, this represents a group with health care need and Disparities must be eliminated to alleviate wider health inequity, organised screening can reduce incomplete diagnostic testing, as can accessible health information.



Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Whether screening for colorectal cancer using the faecal occult blood test (guaiac or immunochemical) reduces coloreCTal cancer mortality and to consider the benefits, harms and potential consequences of screening is reviewed.

Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study.

It is suggested that biennial screening by FOBTs can reduce CRC mortality regardless of the quality of the health system and support attempts to introduce large-scale screening programs into the general population.

Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data

The impact of FOBT in reducing mortality from any cause is uncertain and efficacy of this strategy for CRC screening needs reevaluation.

A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds

The persistent reduction in mortality from CRC in a biennial screening program with Hemoccult-II, and a reduction in RR to less than 0.70 in those adhering to the programme, support attempts to introduce larger scale population screening programmes.

Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial

There was a 13% reduction in colorectal cancer mortality in the intervention group despite an uptake at first invitation of only approximately 50% and further follow up of this population is required to determine whether a significant reduction in the incidence of coloreCTal cancer will be achieved.

Colorectal cancer screening: scientific review.

The recommendation that all men and women aged 50 years or older undergo screening for colorectal cancer is supported by a large body of direct and indirect evidence, but the available evidence does not currently support choosing one test over another.

Fecal occult blood screening for colorectal cancer.

The fecal occult blood test remains a workable approach to reducing the mortality from colorectal cancer provided it is carried out with attention to important variables such as the need for compliance, including the compliance of physicians.

The effect of fecal occult-blood screening on the incidence of colorectal cancer.

The use of either annual or biennial fecal occult-blood testing significantly reduces the incidence of colorectal cancer.

Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

The results from this study, together with the other two published randomized trials of fecal occult blood screening, are consistent in demonstrating a substantial, statistically significant reduction in colorectal cancer mortality from biennial screening.

Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case–control study

A screening programme with immunochemical FOBT can be effective for prevention of advanced colorectal cancer and risk reduction appears to be larger for rectal than for colon cancer.